Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report

Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management.

Authors

Institutions

Publication Details

Journal
Case Reports in Women s Health
Published
2024-09-06
DOI
https://doi.org/10.1016/j.crwh.2024.e00649
Citations
3
Primary Topic
Pelvic floor disorders treatments
Type
article
Field-Weighted Citation Impact
1.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report

Christine Herforth, Philippe E. Zimmern
3 citations
Case Reports in Women s Health
Pelvic floor disorders treatments
1.41
article

Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report

Christine Herforth, Philippe E. Zimmern
article en
3 citations

Abstract

Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management.

Case Reports in Women s HealthVol. 43
The University of Texas Southwestern Medical Center (US)
Zero hunger
Openalex Percentile: Top 18%
Pelvic floor disorders treatments
1.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.